ANNA has joined an initiative to educate and empower all nurses in combatting America’s opioid use and overdose epidemic through free continuing education. According to the Centers for Disease Control, more people die each day from overdoses than from car crashes, and the majority of these overdoses are from prescription drugs. At the same time, the amount of opioids prescribed and sold in the US has quadrupled since 1999, yet the amount of pain Americans reported has not changed.
On July 8, 2016, the Expanding Seniors Receiving Dialysis' Choice Act of 2016 (H.R. 5659), or the ESRD Choice Act of 2016, was introduced in the House of Representatives. The bill would expand Medicare coverage options for dialysis patients by granting individuals with end-stage renal disease access to Medicare Advantage plans.
Ask Your Members of Congress to Support the Bill
On June 24, 2016, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would update payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for renal dialysis services furnished to beneficiaries on or after January 1, 2017.
In April 2016, Billy Rosa, a U.S. nurse living and working as a visiting faculty member at the University of Rwanda in Kigali, Rwanda, contacted ANNA to request support of students that he was helping train to be masters-prepared nephrology nurses. The ANNA Board of Directors voted to provide the University of Rwanda with seven 2-year international electronic ANNA memberships as well as three copies of the ANNA Core Curriculum for Nephrology Nursing.
The Food and Drug Administration (FDA) is requiring labeling changes regarding the recommendations for metformin-containing medicines for diabetes to expand metformin’s use in certain patients with reduced kidney function. The current labeling strongly recommends against use of metformin in some patients whose kidneys do not work normally.